Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT04873245 · ClinicalTrials.gov registry record · Phase 2

Lifestyle Counseling and Medication for Adolescent Weight Management

A Phase 2 study of Obesity, Childhood, sponsored by University of Minnesota.

Active
Registry status
Phase 2
Development phase
120
Enrollment target
1
Study location

NCT04873245 is a Phase 2 study of Obesity, Childhood that is active but no longer recruiting, run by University of Minnesota. The registered enrollment target is 120 participants, below the 341-participant average among 53 other Obesity, Childhood trials with a reported enrollment target (65% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT04873245, a Phase 2 study of Obesity, Childhood, is active but no longer recruiting, sponsored by University of Minnesota.

ACTIVE NOT RECRUITING
Registry status
Phase 2
Development phase
120 participants
Enrollment target
1
Study location

Study Summary

The prevalence of adolescent severe obesity is at an all-time high in the United States and the refractory nature of this disease has led to a serious and challenging conundrum in terms of how to provide effective, safe, scalable, and durable treatments without placing undue strain on the healthcare system. Clinical practice guidelines recommend behavioral interventions as the primary strategy for all ages and classes of obesity - moderate to severe. In 2017, the U.S. Preventive Services Task Force (USPSTF) released updated screening recommendations concluding that comprehensive, intensive behavioral interventions with a total of ≥26 contact hours over a period of 2-12 months resulted in weight loss in youth with obesity, with ≥52 contact hours leading to even greater weight loss and improvements in some cardiometabolic risk factors. However, the practicality of delivering these types of intensive behavioral services to the millions of youth with severe obesity in the U.S. is debatable not only because of the treatment-resistant nature of severe obesity, but also due to the time-commitment, acceptability, and sustainability of this approach for adolescent patients and their families along with the extensive resources required to provide these interventions. Indeed, fewer than 50% of pediatric patients referred for weight management services enroll in treatment, and high attrition rates of up to 50% have been reported in behavioral-based clinical trials and in the clinical setting. Moreover, adherence to behavioral counseling significantly diminishes over time, which too often erodes early weight loss success and ultimately derails durability. The reality of what most patients/families are able to do and the unique physiological and psychosocial features of severe obesity in adolescence do not seem to align well with the degree of intensity of behavioral interventions shown to be effective by the USPSTF. Therefore, a critical appraisal of the feasibility, effectiven

Conditions Studied

Interventions

  • BEHAVIORAL Intensive Behavioral Program
  • DRUG Semaglutide and Behavioral Program

Study Locations (1)

Minnesota

  • University of Minnesota, Delaware Clinical Research Unit - Minneapolis

Trial Details

FieldValue
Enrollment Target 120 participants
Start Date 2022-03-15
Est. Completion 2027-07-31
Phase Phase 2

Sponsor

University of Minnesota

966 total trials

What the Registry Record Tells You About NCT04873245

The ClinicalTrials.gov registry entry for NCT04873245 describes a study currently listed as active not recruiting, categorized as Phase 2. The registered enrollment target is 120 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 341-participant average among 53 other Obesity, Childhood trials with a reported enrollment target (65% lower). The listed sponsor is University of Minnesota, which has 966 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Obesity, Childhood appearing as the primary indexed condition, and to 2 interventions - of which Intensive Behavioral Program is the first listed.

NCT04873245 reports 1 study location spanning 1 distinct geographic area - top geographies include Minnesota.

Frequently Asked Questions

What is clinical trial NCT04873245 about?

NCT04873245 is a clinical study titled "Lifestyle Counseling and Medication for Adolescent Weight Management". The prevalence of adolescent severe obesity is at an all-time high in the United States and the refractory nature of this disease has led to a serious and challenging conundrum in terms of how to provide effective, safe, scalable, and durable treatments without placing undue strain on the healthcare...

What is the current status of trial NCT04873245?

This trial is currently active not recruiting. It is a Phase 2 study. The enrollment target is 120 participants. The study started on 2022-03-15. Estimated completion is 2027-07-31.

What conditions does trial NCT04873245 study?

This clinical trial studies the following conditions: Obesity, Childhood.

What interventions are being tested in trial NCT04873245?

The interventions under investigation include: Intensive Behavioral Program (BEHAVIORAL), Semaglutide and Behavioral Program (DRUG).

Who is sponsoring clinical trial NCT04873245?

This trial is sponsored by University of Minnesota, which has 966 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT04873245 being conducted?

This trial has 1 study location across Minnesota. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Obesity, Childhood

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.